Salvage brentuximab vedotin prior to allogeneic hematopoietic cell transplantation in classical hodgkin lymphoma does not impact survival but reduces the incidence of chronic GVHD: a retrospective study of the EBMT Lymphoma Working Party.
Bazarbachi, A Boumendil, A Finel, H Mohty, M Castagna, L Peggs, K Blaise, D Afanasyev, B Martin, J Sierra, J
Bazarbachi, A
Boumendil, A
Finel, H
Mohty, M
Castagna, L
Peggs, K
Blaise, D
Afanasyev, B
Martin, J
Sierra, J
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Salvage Brentuximab Vedotin prior to allogeneic hematopoietic cell transplantation in classical Hodgkin lymphoma does not impact survival but reduces the incidence of chronic GVHD: a retrospective study of the EBMT Lymphoma Working Party. 2017, 52:s93-s93 Bone Marrow Transplant